Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 13Sarcoma 6Endocrine 5NET 3Genitourinary 2Gastrointestinal 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Myelodysplastic Syndromes 187Leukemia, Myeloid, Acute 159Myeloproliferative Disorders 83Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Primary Myelofibrosis 54Leukemia, Myelomonocytic, Chronic 44Leukemia 35Polycythemia Vera 33Multiple Myeloma 30Hematologic Neoplasms 30Thrombocythemia, Essential 29Lymphoma, Non-Hodgkin 28Leukemia, Biphenotypic, Acute 25Hodgkin Disease 25Lymphoma 23Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Chronic-Phase 14Blastic Plasmacytoid Dendritic Cell Neoplasm 14Neoplasms 13Burkitt Lymphoma 12Mastocytosis 11Leukemia, Myeloid 11Graft vs Host Disease 11Blast Crisis 11Anemia, Refractory, with Excess of Blasts 11Lymphoma, Follicular 10Anemia, Aplastic 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuroectodermal Tumors, Primitive × Myeloid × Clear all
NCT02508038 2025-10-16

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
22 enrolled
CNSLymphoidMyeloidOther hematologic neoplasmSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Leukemia, Myeloid, Acute, Neuroectodermal Tumors, Primitive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡